Commonwealth Equity Services, LLC Novavax Inc Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Novavax Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 39,798 shares of NVAX stock, worth $343,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,798
Previous 43,437 8.38%
Holding current value
$343,854
Previous $550,000 8.55%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$10.71 - $17.11 $38,973 - $62,263
-3,639 Reduced 8.38%
39,798 $503,000
Q2 2024

Jul 31, 2024
SELL
$3.89 - $20.97 $82,397 - $444,186
-21,182 Reduced 32.78%
43,437 $550,000
Q1 2024

Apr 29, 2024
BUY
$3.76 - $6.02 $174,129 - $278,792
46,311 Added 252.95%
64,619 $309,000
Q4 2023

Feb 06, 2024
BUY
$4.8 - $7.67 $4,804 - $7,677
1,001 Added 5.78%
18,308 $88,000
Q3 2023

Oct 23, 2023
BUY
$6.81 - $9.74 $14,988 - $21,437
2,201 Added 14.57%
17,307 $125,000
Q2 2023

Aug 10, 2023
BUY
$6.67 - $9.52 $12,066 - $17,221
1,809 Added 13.6%
15,106 $112,000
Q1 2023

May 11, 2023
SELL
$5.76 - $12.48 $86 - $187
-15 Reduced 0.11%
13,297 $92,000
Q4 2022

Feb 07, 2023
BUY
$8.86 - $25.04 $15,983 - $45,172
1,804 Added 15.68%
13,312 $136,000
Q3 2022

Nov 14, 2022
SELL
$18.2 - $76.12 $30,994 - $129,632
-1,703 Reduced 12.89%
11,508 $209,000
Q2 2022

Jul 19, 2022
BUY
$36.28 - $75.29 $74,374 - $154,344
2,050 Added 18.37%
13,211 $679,000
Q1 2022

May 04, 2022
SELL
$69.73 - $142.9 $111,777 - $229,068
-1,603 Reduced 12.56%
11,161 $822,000
Q4 2021

Jan 31, 2022
BUY
$134.56 - $217.97 $23,009 - $37,272
171 Added 1.36%
12,764 $1.83 Million
Q3 2021

Oct 29, 2021
BUY
$177.8 - $270.58 $488,238 - $743,012
2,746 Added 27.89%
12,593 $2.61 Million
Q2 2021

Aug 11, 2021
BUY
$121.0 - $257.67 $25,773 - $54,883
213 Added 2.21%
9,847 $2.09 Million
Q1 2021

May 04, 2021
SELL
$112.98 - $319.93 $352,158 - $997,221
-3,117 Reduced 24.45%
9,634 $1.75 Million
Q4 2020

Feb 11, 2021
SELL
$78.74 - $139.5 $212,834 - $377,068
-2,703 Reduced 17.49%
12,751 $1.42 Million
Q3 2020

Nov 05, 2020
BUY
$79.44 - $178.51 $443,036 - $995,550
5,577 Added 56.46%
15,454 $1.67 Million
Q2 2020

Aug 12, 2020
SELL
$13.86 - $83.61 $65,280 - $393,803
-4,710 Reduced 32.29%
9,877 $823,000
Q1 2020

May 11, 2020
BUY
$3.93 - $16.0 $4,857 - $19,776
1,236 Added 9.26%
14,587 $198,000
Q4 2019

Feb 05, 2020
BUY
$3.69 - $5.22 $49,265 - $69,692
13,351 New
13,351 $53,000

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $676M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email